Wockhardt gets nod to export 100 mn Sputnik vaccine doses

February 08, 2022 11:09 pm | Updated 11:09 pm IST - HYDERABAD

Wockhardt on Tuesday said it had received the Central Drugs Standard Control Organisation’s (CDSCO) permission to export up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I vaccine.

The bulk vaccine and fill-finish manufacturing facilities at Waluj and Shendra, Aurangabad, respectively, were jointly inspected and approved by Drug Inspectors from CDSCO (West Zone) and Aurangabad State FDA and expert from CDL Kasauli in connection with issue of export NOC, the pharmaceutical and biotechnology firm company said in a release.

Wockhardt has an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines based on the technology transfer from Gamaleya National Research Institute of Epidemiology and Microbiology.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.